Recent results from non-basic glycosidase inhibitors: How structural diversity can inform general strategies for improving inhibition potency

European Journal of Medicinal Chemistry
2022.0

Abstract

This review covers the literature in the past 15 years on glycosidase inhibitors lacking a basic nitrogen (for example iminosugars/azasugars) with a focus on natural terpenoids, and mono- and polycyclic aromatic hydrocarbons. From quite diverse structures, insight into inhibitor structural features that may be applicable to optimisation of all glycosidase inhibitors including iminosugars are identified.

Knowledge Graph

Similar Paper

Recent results from non-basic glycosidase inhibitors: How structural diversity can inform general strategies for improving inhibition potency
European Journal of Medicinal Chemistry 2022.0
Plant Secondary Metabolites with α-Glucosidase Inhibitory Activity
Structure and Health Effects of Natural Products on Diabetes Mellitus 2021.0
Recent Developments in the Synthesis of Polyhydroxylated Indolizidines
European Journal of Organic Chemistry 2022.0
Polyhydroxylated azetidine iminosugars: Synthesis, glycosidase inhibitory activity and molecular docking studies
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis, computational study and glycosidase inhibitory activity of polyhydroxylated conidine alkaloids—a bicyclic iminosugar
Organic & Biomolecular Chemistry 2010.0
Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp2-iminosugar conjugates against glycosidases: A structure–activity relationship study in Gaucher fibroblasts
European Journal of Medicinal Chemistry 2016.0
Glycosidase inhibitors: update and perspectives on practical use
Glycobiology 2003.0
Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors
Phytochemistry 2015.0
Five-membered iminocyclitol α-glucosidase inhibitors: Synthetic, biological screening and in silico studies
Bioorganic & Medicinal Chemistry 2013.0
Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase
Bioorganic & Medicinal Chemistry Letters 2009.0